Ditchcarbon
  • Contact
  1. Organizations
  2. Curia
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 17 days ago

Curia

Company website

Curia Global, commonly referred to as Curia, is a leading contract research, development, and manufacturing organisation headquartered in the United States. Established in 2019, Curia has rapidly expanded its operational footprint across North America and Europe, positioning itself as a key player in the pharmaceutical and biotechnology sectors. Specialising in drug development and manufacturing, Curia offers a comprehensive suite of services, including analytical testing, formulation development, and commercial manufacturing. What sets Curia apart is its commitment to quality and innovation, ensuring that clients receive tailored solutions that meet stringent regulatory standards. With a strong market presence, Curia has achieved significant milestones, including strategic acquisitions that enhance its capabilities. The company is recognised for its expertise in complex drug modalities, making it a trusted partner for clients seeking to navigate the complexities of drug development.

DitchCarbon Score

How does Curia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Curia's score of 35 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Let us know if this data was useful to you

Curia's reported carbon emissions

In 2021, Curia Global, Inc. reported total carbon emissions of approximately 41,290,410 kg CO2e for Scope 1 and about 46,508,720 kg CO2e for Scope 2, with no data available for Scope 3 emissions. This data reflects the company's operational footprint and highlights its commitment to transparency in emissions reporting. Curia has made significant strides in its climate commitments, having pledged to achieve net-zero emissions across all scopes by 2050. This commitment is part of the Science Based Targets initiative (SBTi), which underscores the company's dedication to aligning its emissions reduction strategies with global climate goals. The net-zero commitment was formalised in 2024, indicating a proactive approach to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. As Curia continues to develop its sustainability initiatives, it remains focused on reducing its carbon footprint and contributing to a more sustainable future.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021
Scope 1
41,290,410
Scope 2
46,508,720
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Curia's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Curia is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Curia is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 17 days ago

Phastar

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Bureau Veritas

FR
•
Other services (93)
Updated 11 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Avid Bioservices

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy